Integra LifeSciences Holdings (IART)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 28,411 | 111,526 | 238,920 | 197,230 | 151,370 |
| Total assets | US$ in thousands | 4,037,420 | 3,781,990 | 3,889,760 | 3,782,380 | 3,615,140 |
| Operating ROA | 0.70% | 2.95% | 6.14% | 5.21% | 4.19% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $28,411K ÷ $4,037,420K
= 0.70%
Integra LifeSciences Holdings' operating return on assets (operating ROA) has shown fluctuating trends over the past five years. The ratio increased from 4.19% as of December 31, 2020, to 6.14% by December 31, 2022, indicating improved efficiency in generating operating profits relative to its asset base during this period.
However, the operating ROA declined significantly to 2.95% by December 31, 2023, and further dropped to 0.70% by December 31, 2024. This downward trend suggests a decrease in the company's ability to generate operating income from its assets, which could be attributed to factors such as declining revenues, increasing operating expenses, or less effective asset utilization.
It is essential for Integra LifeSciences Holdings to evaluate the underlying reasons for the decline in operating ROA and take appropriate measures to enhance operational efficiency and asset utilization in order to improve profitability in the future.
Peer comparison
Dec 31, 2024